Event Brief
Lotte Biologics signs CDMO deal with U.S. firm
Filed: Mar 31, 2026 at 10:07 PM ET
Summary: Lotte Biologics partners with a U.S. company for antibody drug substance production.
WHO: Lotte Biologics Co.
WHAT: signed a CDMO deal for antibody drug substance
WHEN: Mar 31, 2026 at 9:35 PM ET
WHERE: Seoul
WHY: to enhance production capabilities for antibody drugs
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →